Viewing Study NCT03871257


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-25 @ 4:09 PM
Study NCT ID: NCT03871257
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2019-03-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module